The DMTN Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from the human A-549 cell line, designed to disrupt the DMTN gene encoding dematin. Dematin is an actin-binding protein that bundles filaments and links the spectrin-actin cytoskeleton to the plasma membrane. This polyclonal knockout format offers a heterogeneous pool of edited cells that collectively provide a broad functional knockout, making it suitable for loss-of-function studies where clonal homogeneity is not required, in a well-characterized lung adenocarcinoma background.
The parental A-549 cell line is a hypotriploid human epithelial line established from the lung adenocarcinoma of a 58-year-old Caucasian male. It is extensively employed as an in vitro model for human alveolar type II epithelial cells, finding widespread use in cancer biology, drug metabolism, and toxicology research. These cells display epithelial morphology and express type II pneumocyte markers, ensuring a physiologically relevant pulmonary context. Their robust growth and thoroughly documented genetic background facilitate reproducible experimental approaches.
Dematin, encoded by DMTN, is a member of the villin/gelsolin family that bundles F-actin and anchors it to the spectrin-based membrane skeleton by interacting with ??-spectrin, adducin, and protein 4.1R. This scaffolding function is essential for maintaining cell shape and mechanical stability, most notably in erythrocytes where mutations cause hereditary spherocytosis. In non-erythroid cells, dematin is regulated by RhoA and Rac1 GTPases, PKA, and calmodulin, integrating cues to modulate actin dynamics, membrane-cytoskeleton adhesion, and potentially cell motility. Mechanistically, dematin acts downstream of RhoA/Rac1, forming a complex with spectrin, F-actin, and adducin that stabilizes the cortical network.
Within A-549 lung adenocarcinoma cells, DMTN is poised to influence actin-dependent processes such as migration, invasion, and adhesion??behaviors critical for cancer progression and metastasis. This polyclonal knockout model permits systematic dissection of dematin??s contributions to cytoskeletal organization and signaling in an alveolar epithelial malignancy context. Loss of dematin may disrupt actin balance, altering cellular responses to chemotactic gradients, mechanical forces, or chemotherapeutic agents, thereby offering a robust platform to study how cytoskeletal regulators govern tumor cell behavior.
This product supports a wide array of research applications, including western blotting and immunofluorescence to confirm dematin ablation and visualize cytoskeletal components; phalloidin staining to assess F-actin organization; and functional assays (wound healing, transwell migration, adhesion) to quantify changes in motility. Co-immunoprecipitation can examine altered protein interactions within the spectrin-actin network, while RT-qPCR, flow cytometry, and phospho-signaling analyses probe gene expression and pathway activation. These polyclonal knockout cells are an invaluable tool for advancing studies in actin regulation, cancer biology, and cytoskeletal disorders. For further details, please contact Ascent Research.
